Comparison Chart BioLineRx Ltd.

Equities

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 06:19:41 02/06/2024 pm IST			5-day change	1st Jan Change
18.3 ^ILa	+1.67%		+5.78%	-52.09%

30/05	BioLineRx Ltd Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications in Sickle Cell Disease	CI
28/05	Transcript : BioLineRx Ltd., Q1 2024 Earnings Call, May 28, 2024

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	BIOLINERX LTD.	Bio Therapeutic Drugs	+1.67%	+5.78%	-52.09%	-52.34%	-85.93%	5.81Cr